RTI Surgical today announced a milestone of 5,000 implants of Fortilink-C, -TS and -L interbody fusion (IBF) systems with TETRAfuse 3D technology in the USA.
“In my over 500 implantations, I have been extremely satisfied with the Fortilink-TS and -C IBF devices”, said Mario Brkaric, co-founder of the Indiana Spine Center (Lafayette, USA). “I have had no intraoperative or postoperative issues and have seen no issues with cage migration. Visualisation in the office on postoperative X-rays has also been great.”
RTI Surgical commercially launched the Fortilink-C IBF system for use in anterior cervical discectomy and fusion (ACDF) surgeries in October 2017. It was the first in a family of devices to incorporate RTI Surgical’s TETRAfuse 3D Technology intended for use in patients with degenerative disc disease.
Following the successful launch of the Fortilink-C IBF system, the company commercially launched both the Fortilink-TS and -L IBF systems with TETRAfuse 3D technology to be used in lateral lumbar interbody fusion (LLIF) and transforaminal lumbar interbody fusion (TLIF) or bilateral posterior lumbar interbody fusion (PLIF) surgeries, respectively. Since launch, the Fortilink family of devices has experienced significant growth in the total number of implants from Q1 2018 to Q1 2019.
“This milestone of 5,000 implants for the Fortilink family of devices with TETRAfuse 3D Technology reinforces surgeon confidence in this award-winning technology,” said Camille Farhat, president and CEO, RTI Surgical. “Adding to this confidence, we are investing in our commitment to clinical data through our FORTE study to show definitive outcomes for patients for pain reduction and procedural and long-term performance.”
TETRAfuse 3D technology is featured in the growing family of Fortilink IBF devices to help drive optimal outcomes for patients undergoing spinal fusion procedures. It features a nano-rough surface with antibacterial characteristics designed to participate in fusion without compromising mechanical integrity or radiographic visibility. TETRAfuse 3D technology recently won a 2019 MedTech Breakthrough Award for “Best New Technology Solution – Orthopedics”.
